Evidence map›Paper›PMID 34829694›Full record

ArticleAntioxidants (Basel, Switzerland)2021

Probiotic Enhancement of Antioxidant Capacity and Alterations of Gut Microbiota Composition in 6-Hydroxydopamin-Induced Parkinson's Disease Rats.

Shu-Ping Tsao, Bira Arumndari Nurrahma, Ravi Kumar, Chieh-Hsi Wu, Tu-Hsueh Yeh, Ching-Chi Chiu, Yen-Peng Lee, Yi-Chi Liao, Cheng-Hsieh Huang, Yao-Tsung Yeh and 1 more

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 3 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 3 syntheses or guidelines pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Review
  7. Article
  8. Gut-Brain Signaling in Parkinson's Disease: A Narrative Review.International journal of molecular sciences · 2026
    Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Shu-Ping TsaoPh.D. Program in Drug Discovery and Development Industry, College of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan.ORCID 0000-0002-3866-1117
Bira Arumndari NurrahmaGraduate Institute of Metabolism and Obesity Sciences, College of Nutrition, Taipei Medical University, Taipei 11031, Taiwan.
Ravi KumarGraduate Institute of Metabolism and Obesity Sciences, College of Nutrition, Taipei Medical University, Taipei 11031, Taiwan.
Chieh-Hsi WuSchool of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan.ORCID 0000-0002-2006-8243
Tu-Hsueh YehDepartment of Neurology, Taipei Medical University Hospital, Taipei 11031, Taiwan.
Ching-Chi ChiuNeuroscience Research Center, Chang Gung Memorial Hospital at Linkou, Taoyuan 33305, Taiwan.ORCID 0000-0002-1827-8049
Yen-Peng LeeGraduate Institute of Metabolism and Obesity Sciences, College of Nutrition, Taipei Medical University, Taipei 11031, Taiwan.
Yi-Chi LiaoGraduate Institute of Metabolism and Obesity Sciences, College of Nutrition, Taipei Medical University, Taipei 11031, Taiwan.
Cheng-Hsieh HuangAging and Disease Prevention Research Center, Fooyin University, Kaohsiung 83102, Taiwan.ORCID 0000-0001-7567-2897
Yao-Tsung YehAging and Disease Prevention Research Center, Fooyin University, Kaohsiung 83102, Taiwan.ORCID 0000-0002-7780-7983
Hui-Yu HuangGraduate Institute of Metabolism and Obesity Sciences, College of Nutrition, Taipei Medical University, Taipei 11031, Taiwan.
Taipei Medical University · TWChang Gung University of Science and Technology · TWFooyin University · TWKaohsiung Medical University · TWTaipei Medical University Hospital · TW

Funding

Bioflag Biotech Co., Ltd A-109-065Ministry of Science and Technology, Taiwan MOST109-2320-B-038-058-MY3Ministry of Science and Technology, Taiwan MOST109-2410-H-038-016-MY3
6 · The paper itself

Abstract

Oxidative stress plays a key role in the degeneration of dopaminergic neurons in Parkinson's disease (PD), which may be aggravated by concomitant PD-associated gut dysbiosis. Probiotics and prebiotics are therapeutically relevant to these conditions due to their antioxidant, anti-inflammatory, and gut microbiome modulation properties. However, the mechanisms by which probiotic/prebiotic supplementation affects antioxidant capacity and the gut microbiome in PD remains poorly characterized. In this study, we assessed the effects of a

Indexed as

antioxidant activitiesfecal microbiota compositionneuroprotectionParkin-son’s diseaseprobiotics

Identifiers

PMID34829694
PMCPMC8615185
OpenAlexW3211533091

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.